Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
EPOR | KIT | KIT: Mast/stem cell growth factor receptor precursor | 34.80 | Evidence | |||||
EPOR | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 28.70 | Evidence | |||||
EPOR | CRKL | CRKL: Crk-like protein | 28.70 | Evidence | |||||
EPOR | INSR | INSR: Insulin receptor precursor | 28.20 | Evidence | |||||
EPOR | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 24.90 | Evidence | |||||
EPOR | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 24.80 | Evidence | |||||
EPOR | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 24.80 | Evidence | |||||
EPOR | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 22.90 | Evidence | |||||
EPOR | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 22.90 | Evidence | |||||
EPOR | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 21.10 | Evidence | |||||
EPOR | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 16.40 | Evidence | |||||
EPOR | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 15.70 | Evidence | |||||
EPOR | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 15.10 | Evidence | |||||
EPOR | DUSP6 | DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 | 15.10 | Evidence | |||||
EPOR | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 15.00 | Evidence | |||||
EPOR | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 14.50 | Evidence | |||||
EPOR | STAM2 | STAM2: Signal transducing adapter molecule 2 | 13.90 | Evidence | |||||
EPOR | STAT3 | 13.00 | Evidence | ||||||
EPOR | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 13.00 | Evidence | |||||
EPOR | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 11.90 | Evidence | |||||
EPOR | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 11.90 | Evidence | |||||
EPOR | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 9.94 | Evidence | |||||
EPOR | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 9.92 | Evidence | |||||
EPOR | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 9.92 | Evidence | |||||
EPOR | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 9.92 | Evidence | |||||
EPOR | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 9.92 | Evidence | |||||
EPOR | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 9.89 | Evidence | |||||
EPOR | SYK | SYK: Tyrosine-protein kinase SYK | 9.71 | Evidence | |||||
EPOR | LYN | LYN: Tyrosine-protein kinase Lyn | 8.55 | Evidence | |||||
EPOR | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 7.40 | Evidence | |||||
EPOR | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 7.40 | Evidence | |||||
EPOR | DUSP1 | DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 | 7.12 | Evidence | |||||
EPOR | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 6.78 | Evidence | |||||
EPOR | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 6.52 | Evidence | |||||
EPOR | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 6.52 | Evidence | |||||
EPOR | JAK1 | 6.52 | Evidence | ||||||
EPOR | VAV1 | VAV1, VAV: Proto-oncogene vav | 6.52 | Evidence | |||||
EPOR | RPS6KA3 | RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 | 6.52 | Evidence | |||||
EPOR | CSK | CSK: Tyrosine-protein kinase CSK | 6.52 | Evidence | |||||
EPOR | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 6.52 | Evidence | |||||
EPOR | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 6.52 | Evidence | |||||
EPOR | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 6.52 | Evidence | |||||
EPOR | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 6.52 | Evidence | |||||
EPOR | CTTN | CTTN, EMS1: Src substrate cortactin | 6.52 | Evidence | |||||
EPOR | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 6.14 | Evidence | |||||
EPOR | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 5.88 | Evidence | |||||
EPOR | APS | SH2B2, APS: SH2B adapter protein 2 | 5.88 | Evidence | |||||
EPOR | RPS6KA2 | RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 | 5.87 | Evidence | |||||
EPOR | MKNK1 | MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 | 5.87 | Evidence | |||||
EPOR | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 5.41 | Evidence | |||||
EPOR | SOS1 | SOS1: Son of sevenless homolog 1 | 5.40 | Evidence | |||||
EPOR | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 5.40 | Evidence | |||||
EPOR | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 5.09 | Evidence | |||||
EPOR | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 4.67 | Evidence | |||||
EPOR | DUSP3 | DUSP3, VHR: Dual specificity protein phosphatase 3 | 4.18 | Evidence | |||||
EPOR | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 4.12 | Evidence | |||||
EPOR | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 3.86 | Evidence | |||||
EPOR | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 3.34 | Evidence | |||||
EPOR | SPTA1 | SPTA1, SPTA: Spectrin alpha chain, erythrocyte | 3.11 | Evidence |